Skip to content

Precise induction of propofol combined with remifentanil for sedation/anesthesia during gastroscopy in obese people: a study of dose calculation formula

Precise induction of propofol combined with remifentanil for sedation/anesthesia during gastroscopy in obese people: a study of dose calculation formula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114366
Enrollment
Unknown
Registered
2025-12-11
Start date
2025-12-22
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

Group 1:ED50 and ED95 of propofol during anesthesia induction in Class I obese patients
Group 2:ED50 and ED95 of propofol during anesthesia induction in Class II obese patients
Group 3:ED50 and ED95 of propofol during anesthesia induction in Class III obese patients

Sponsors

The First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age: between 18 and 60 years old. Gender is not limited; 2. Preoperative gastroscopy for sedation/anesthesia; 3. Body mass index (BMI) : 30-50 kg/m2; 4. ASA classification: I-III; 5. agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with central nervous system disease, mental illness or language communication disorder; 2. Patients with a history of abnormal anesthesia recovery; 3. Patients allergic to propofol, remifentanil and other anesthetic drugs; 4. Alcohol dependence; 5. Llactating patients or preoperative long-term use of opioids or non-steroidal drugs; 6. Long-term use of ß-blockers and heart rate <50 beats/min; 7. Severe heart, brain, liver, kidney, respiratory dysfunction or dysfunction; 8. Subjects do not cooperate, or the investigator judges that it may be difficult for them to complete the study; 9. Other conditions judged by the investigator to be ineligible for inclusion.

Design outcomes

Primary

MeasureTime frame
ED50 and ED95 of propofol during anesthesia induction ;

Secondary

MeasureTime frame
Success rate of insertion;The incidence of hypoxia;Duration of hypoxia;Severe hypoxia;Awakening time;Recovery time of orientation;The incidence of body movement;The Brice questionnaire;

Countries

China

Contacts

Public ContactMengxia Wang

The First Affiliated Hospital of Jinan University

wmx_strive@163.com+86 156 2646 7868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026